David J. Schlanger - Jun 27, 2022 Form 4/A - Amendment Insider Report for Progyny, Inc. (PGNY)

Role: Executive Chairman, Director
Signature: /s/ Mark Livingston, Attorney-in-Fact
Stock symbol: PGNY
Transactions as of: Jun 27, 2022
Transactions value $: $1,321
Form type: 4/A - Amendment
Date filed: 2/6/2023, 03:57 PM
Date Of Original Report: Jun 29, 2022
Previous filing: Apr 7, 2022
Next filing: Aug 10, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PGNY	Common Stock	Options Exercise	$1.32K	+1.45K	+1.73%	$0.91^*	85.5K	Jun 27, 2022	Direct	F1
holding	PGNY	Common Stock						84K	Jun 27, 2022	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PGNY	Stock Option (Right to Buy)	Options Exercise	$0	-1.45K	-0.08%	$0.00	1.73M	Jun 27, 2022	Common Stock	1.45K	$0.91	Direct	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This Form 4/A is being filed to reflect the stock option exercise reported in Table II, which was inadvertently omitted from the original Form 4 filing (the "Original Filing"). The total securities reported in Column 5 of Table I has also been updated to reflect the number of shares of common stock held by the Reporting Person as of June 29, 2022, the date of the Original Filing.
F2	The amount reported in Column 5 of Table I reflects the aggregate amount of shares held by the Reporting Person after the sale previously and correctly reported in the Original Filing.
F3	These options are fully vested and exercisable.
F4	The amount reported in Column 9 of Table II has been updated to reflect the number of derivative securities held by the Reporting Person as of the date of the Original Filing.